Florham Park partner Lynne Anderson, along with Washington, D.C. partner Peter Blenkinsop and counsel Katherine Armstrong spoke at Seton Hall’s U.S. Healthcare Compliance Certification Program, June 13-16.
The event offered a comprehensive overview of state, federal and international law governing prescription drugs, medical devices and health care fraud. Topics included privacy and data protection; FDA approval and regulation; anti-kickback laws; federal and state false claims acts; Sunshine Law; Foreign Corrupt Practices Act; government investigations; health care fraud sentencing, penalties and damages; OIG Compliance; and prescription drug and device marketing. Attendees included representatives from pharmaceutical companies and hospitals.
Lynne participated in the panel titled, “Being the Focus of a Government Investigation” which provided the perspective of dealing with an employee whistleblower. She was joined by Mike Doyle of the Federal Bureau of Investigation; Jacob Elberg of the U.S. Attorney’s Office, District of New Jersey; Maureen Ruane of Lowenstein Sandler P.C.; and Jim Sheehan of the Office of the New York Attorney General. Professor Timothy Glynn of Seton Hall Law School moderated.
Peter and Katherine gave a presentation titled “Why Data Privacy Matters: Understanding, Risks, Benefits and Strategy,” providing insight into identifying and addressing compliance risks and building effective compliance programs.